Liontrust Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Liontrust Investment Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Buy	+1,371	New	+$141K	﹤0.01%	191

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Liontrust Investment Partners's LMAT Position: Q2 2026 in Review

Liontrust Investment Partners opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 1,371 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #191 among its holdings.

326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Liontrust Investment Partners held 1,371 shares of LeMaitre Vascular worth $132K as of Q2 2026.
LeMaitre Vascular was a new Liontrust Investment Partners position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Liontrust Investment Partners's portfolio in Q2 2026, its #191 holding.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.